|
1. Christophers, E. (2001) Psoriasis-epidemiology and clinical spectrum. Clinical and Experimental Dermatology 26, 314-320 2. Gelfand, J. M., Stern, R. S., Nijsten, T., Feldman, S. R., Thomas, J., Kist, J., Rolstad, T., and Margolis, D. J. (2005) The prevalence of psoriasis in African Americans: Results from a population-based study. Journal of the American Academy of Dermatology 52, 23-26 3. Garcia, C., El-Qutob, D., Martorell, A., Febrer, I., Rodriguez, M., Cerda, J. C., and Felix, R. (2007) Sensitization in early age to food allergens in children with atopic dermatitis. Allergologia et Immunopathologia (Madr) 35, 15-20 4. Liu, Y., Krueger, J. G., and Bowcock, A. M. (2007) Psoriasis: Genetic associations and immune system changes. Genes and Immunity 8, 1-12 5. Wolters, M. (2005) Diet and psoriasis: Experimental data and clinical evidence. The British Journal of Dermatology 153, 706-714 6. 吳孟澤 (2006) 皮膚的免疫功能,科學發展,403期(7),22-27頁 7. Vickery, B. P. (2007) Skin barrier function in atopic dermatitis. Current Opinion in Pediatrics 19, 89-93 8. Heller, F., and Duchmann, R. (2003) Intestinal flora and mucosal immune responses. International Journal of Medical Microbiology 293, 77-86 9. Neaville, W. A., Tisler, C., Bhattacharya, A., Anklam, K., Gilbertson-White, S., Hamilton, R., Adler, K., Dasilva, D. F., Roberg, K. A., Carlson-Dakes, K. T., Anderson, E., Yoshihara, D., Gangnon, R., Mikus, L. D., Rosenthal, L. A., Gern, J. E., and Lemanske, R. F., Jr. (2003) Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. The Journal of Allergy and Clinical Immunology 112, 740-746 10. Jacobi, A., Antoni, C., Manger, B., Schuler, G., and Hertl, M. (2005) Infliximab in the treatment of moderate to severe atopic dermatitis. Journal of the American Academy of Dermatology 52, 522-526 11. Leung, D. Y., and Bieber, T. (2003) Atopic dermatitis. Lancet 361, 151-160 12. Hays, T., and Wood, R. A. (2005) A systematic review of the role of hydrolyzed infant formulas in allergy prevention. Archives of Pediatrics and Adolescent Medicine 159, 810-816 13. Rautava, S. (2007) Potential uses of probiotics in the neonate. Seminars in Fetal & Neonatal Medicine 12, 45-53 14. Weston, S., Halbert, A., Richmond, P., and Prescott, S. L. (2005) Effects of probiotics on atopic dermatitis: A randomised controlled trial. Archives of Disease in Childhood 90, 892-897 15. Isolauri, E. (2004) Dietary modification of atopic disease: Use of probiotics in the prevention of atopic dermatitis. Current Allergy and Asthma Reports 4, 270-275 16. Mehlis, S. L., and Gordon, K. B. (2003) The immunology of psoriasis and biologic immunotherapy. Journal of the American Academy of Dermatology 49, S44-50 17. Brown, S., and Reynolds, N. J. (2006) Atopic and non-atopic eczema. British Medical Journal 332, 584-588 18. Lebwohl, M. (2003) Psoriasis. The Lancet 361, 1197-1204 19. Schon, M. P., and Boehncke, W. H. (2005) Psoriasis. The New England Journal of Medicine 352, 1899-1912 20. Leung, D. Y., Boguniewicz, M., Howell, M. D., Nomura, I., and Hamid, Q. A. (2004) New insights into atopic dermatitis. The Journal of Clinical Investigation 113, 651-657 21. Guilhou, J. J., and Moles, J. P. (2008) New hypotheses in the genetics of psoriasis and other 'complex' diseases. Dermatology (Basel, Switzerland) 216, 87-92 22. Wuthrich, B., Cozzio, A., Roll, A., Senti, G., Kundig, T., and Schmid-Grendelmeier, P. (2007) Atopic eczema: Genetics or environment? Annals of Agricultural and Environmental Medicine 14, 195-201 23. Bieber, T. (2008) Atopic dermatitis. The New England Journal of Medicine 358, 1483-1494 24. Novak, N., Bieber, T., and Leung, D. Y. (2003) Immune mechanisms leading to atopic dermatitis. The Journal of Allergy and Clinical Immunology 112, S128-139 25. Boniface, K., Diveu, C., Morel, F., Pedretti, N., Froger, J., Ravon, E., Garcia, M., Venereau, E., Preisser, L., Guignouard, E., Guillet, G., Dagregorio, G., Pene, J., Moles, J. P., Yssel, H., Chevalier, S., Bernard, F. X., Gascan, H., and Lecron, J. C. (2007) Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. Journal of Immunology 178, 4615-4622
26. Johnston, G. A., Bilbao, R. M., and Graham-Brown, R. A. (2004) The use of dietary manipulation by parents of children with atopic dermatitis. The British Journal of Dermatology 150, 1186-1189 27. Bovenschen, H. J., Seyger, M. M., and Van de Kerkhof, P. C. (2005) Plaque psoriasis vs. atopic dermatitis and lichen planus: A comparison for lesional T-cell subsets, epidermal proliferation and differentiation. The British Journal of Dermatology 153, 72-78 28. Traub, M., and Marshall, K. (2007) Psoriasis-pathophysiology, conventional, and alternative approaches to treatment. Alternative Medicine Review 12, 319-330 29. De Rie, M. A., Goedkoop, A. Y., and Bos, J. D. (2004) Overview of psoriasis. Dermatologic Therapy 17, 341-349 30. Jordon, R. E., and Sell, S. (1989) Humoral immunopathological mechanisms in the skin. Immunology Series 46, 109-122 31. Beissert, S., Cavazzana, I., Mascia, F., Meroni, P., Pastore, S., Tessari, G., and Girolomoni, G. (2006) Mechanisms of immune-mediated skin diseases: An overview. Clinical and Experimental Rheumatology 24, S1-6 32. 李淑慧、鍾明華 (2000) 表皮藍罕氏細胞在病毒感染上所扮演之角色,行政院農業委員會家畜衛生試驗所,研究報告 No. 36 : 69-75頁 33. Goldsby, R. A., Kindt, T. J., and Osborne, B. A. (2000) Kuby Immunology. 4nd ed. W.H. Freeman and Company, New York 34. Nickoloff, B. J., and Nestle, F. O. (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. The Journal of Clinical Investigation 113, 1664-1675 35. Griffiths, C. E., and Barker, J. N. (2007) Pathogenesis and clinical features of psoriasis. Lancet 370, 263-271 36. Sabat, R., Philipp, S., Hoflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H. D., Sterry, W., and Wolk, K. (2007) Immunopathogenesis of psoriasis. Experimental Dermatology 16, 779-798 37. Bowcock, A. M., and Krueger, J. G. (2005) Getting under the skin: the immunogenetics of psoriasis. Nature Reviews 5, 699-711 38. Gaspari, A. A. (2006) Innate and adaptive immunity and the pathophysiology of psoriasis. Journal of the American Academy of Dermatology 54, S67-80 39. Smith, C. H., and Barker, J. N. (2006) Psoriasis and its management. British Medical Journal (Clinical Research ed.) 333, 380-384 40. Freedberg, I. M., Eisen, A. Z., Wolff, K., Austen, K. F., Goldsmith, L. A., Katz, S. (2003) Psoriasis. Fitzpatrick's Dermatology in General Medicine. McGraw Hill, New York 1, 169-193 41. Roebuck, H. L. (2006) Newer treatment options for patients with moderate-to-severe psoriatic disease. The Nurse Practitioner 31, 5-11 42. Salomon, J., Szepietowski, J. C., and Proniewicz, A. (2003) Psoriatic nails: A prospective clinical study. Journal of Cutaneous Medicine and Surgery 7, 317-321 43. Krueger, J. G., and Bowcock, A. (2005) Psoriasis pathophysiology: Current concepts of pathogenesis. Annals of the Rheumatic Diseases 64 Suppl 2, ii30-36
44. Eyre, R. W., and Krueger, G. G. (1982) Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and 'reverse' Koebner reactions. The British Journal of Dermatology 106, 153-159 45. Telfer, N. R., Chalmers, R. J., Whale, K., and Colman, G. (1992) The role of streptococcal infection in the initiation of guttate psoriasis. Archives of Dermatology 128, 39-42 46. Gudjonsson, J. E., Thorarinsson, A. M., Sigurgeirsson, B., Kristinsson, K. G., and Valdimarsson, H. (2003) Streptococcal throat infections and exacerbation of chronic plaque psoriasis: A prospective study. The British Journal of Dermatology 149, 530-534 47. Tsankov, N., Angelova, I., and Kazandjieva, J. (2000) Drug-induced psoriasis. Recognition and management. American Journal of Clinical Dermatology 1, 159-165 48. Naldi, L., Chatenoud, L., and Linder, D. (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. The Journal of Investigative Dermatology 125, 61–67 49. Dellavalle, R. P., and Johnson, K. R. (2005) Do smoking, obesity, and stress cause psoriasis? The Journal of Investigative Dermatology 125, vi-vii 50. Herron, M. D., Hinckley, M., Hoffman, M. S., Papenfuss, J., Hansen, C. B., Callis, K. P., and Krueger, G. G. (2005) Impact of obesity and smoking on psoriasis presentation and management. Archives of Dermatology 141, 1527-1534 51. Behnam, S. M., Behnam, S. E., and Koo, J. Y. (2005a) Alcohol as a risk factor for plaque-type psoriasis. Cutis; Cutaneous Medicine for the Practitioner 76, 181-185 52. Poikolainen, K., Reunala, T., and Karvonen, J. (1994) Smoking, alcohol and life events related to psoriasis among women. The British Journal of Dermatology 130, 473-477 53. Bo, K., Thoresen, M., and Dalgard, F. (2008) Smokers report more psoriasis, but not atopic dermatitis or hand eczema: Results from a Norwegian population survey among adults. Dermatology (Basel, Switzerland) 216, 40-45 54. Fortes, C., Mastroeni, S., Leffondre, K., Sampogna, F., Melchi, F., Mazzotti, E., Pasquini, P., and Abeni, D. (2005) Relationship between smoking and the clinical severity of psoriasis. Archives of Dermatology 141, 1580-1584 55. Behnam, S. M., Behnam, S. E., and Koo, J. Y. (2005b) Smoking and psoriasis. Skinmed 4, 174-176 56. Favato, G. (2008) High incidence of smoking habit in psoriatic patients. The American Journal of Medicine 121, e17 57. Lebwohl, M. (2005) A clinician's paradigm in the treatment of psoriasis. Journal of the American Academy of Dermatology 53, S59-69 58. Lebwohl, M., Ting, P. T., and Koo, J. Y. (2005) Psoriasis treatment: traditional therapy. Annals of the Rheumatic Diseases 64 Suppl 2, ii83-86 59. Takahashi, H., and Iizuka, H. (2004) Treatment of the keratinizing skin disorder, psoriasis, by topical vitamin D3. Clinical Calcium 14, 129-132 60. Fogh, K., and Kragballe, K. (2004) New vitamin D analogs in psoriasis. Current Drug Targets 3, 199-204 61. Nijsten, T. E., and Stern, R. S. (2003) The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: A cohort study. Journal of Investigative Dermatology 121, 252-258 62. Schwarz, T. (2005a) Mechanisms of UV-induced immunosuppression. The Keio Journal of Medicine 54, 165-171 63. Herr, H., Cho, H. J., and Yu, S. (2007) Burns caused by accidental overdose of photochemotherapy (PUVA). Burns 33, 372-375 64. Strober, B. E., and Menon, K. (2005) Folate supplementation during methotrexate therapy for patients with psoriasis. Journal of the American Academy of Dermatology 53, 652-659 65. Naldi, L., and Griffiths, C. E. (2005) Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. The British Journal of Dermatology 152, 597-615 66. Fredriksson, T., and Pettersson, U. (1978) Severe psoriasis--oral therapy with a new retinoid. Dermatologica 157, 238-244 67. Nikam, B. P., Amladi, S., and Wadhwa, S. L. (2006) Acitretin. Indian Journal of Dermatology, Venereology and Leprology 72, 167-172 68. Lebwohl, M., Menter, A., Koo, J., and Feldman, S. R. (2004) Combination therapy to treat moderate to severe psoriasis. Journal of the American Academy of Dermatology 50, 416-430 69. Alka, D., and Silonie, S. (2006) Biologic therapy in psoriasis. Indian Journal of Dermatology Venereology and Leprology 72, 256-265 70. Sauder, D. N., and Mamelak, A. J. (2004) Understanding the new clinical landscape for psoriasis: A comparative review of biologics. Journal of Cutaneous Medicine and Surgery 8, 205-212 71. Smith, C. H., Anstey, A. V., Barker, J. N., Burden, A. D., Chalmers, R. J., Chandler, D., Finlay, A. Y., Grifitths, C. E., Jackson, K., McHugh, N. J., McKenna, K. E., Reynolds, N. J., and Ormerod, A. D. (2005) British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. The British Journal of Dermatology 153, 486-497 72. Koo, J., and Khera, P. (2005) Update on the mechanisms and efficacy of biological therapies for psoriasis. Journal of Dermatological Science 38, 75-87 73. Gottlieb, A. B. (2005) Alefacept for psoriasis and psoriatic arthritis. Annals of the Rheumatic Diseases 64 Suppl 4, iv58-60 74. Krueger, J. G. (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. Journal of the American Academy of Dermatology 46, 1-23 75. Lebwohl, M., Christophers, E., Langley, R., Ortonne, J. P., Roberts, J., and Griffiths, C. E. (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Archives Dermatology 139, 719-727 76. Gribetz, C. H., Blum, R., Brady, C., Cohen, S., and Lebwohl, M. (2005) An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis. Journal of the American Academy of Dermatology 53, 73-75 77. Gottlieb, A. B. (2004) Alefacept is well tolerated in patients with chronic plaque psoriasis. Journal of Cutaneous Medicine and Surgery 8 Suppl 2, 14-19 78. Nelson, A. A., Pearce, D. J., Fleischer, A. B., Balkrishnan, R., and Feldman, S. R. (2006) New treatments for psoriasis: which biologic is best? The Journal of Dermatological Treatment 17, 96-107 79. Gottlieb, A. B., Gordon, K. B., Lebwohl, M. G., Caro, I., Walicke, P. A., Li, N., and Leonardi, C. L. (2004a) Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis. Journal of Drugs in Dermatology 3, 614-624 80. Leonardi, C. L. (2004) Current concepts and review of efalizumab in the treatment of psoriasis. Dermatologic Clinics 22, 427-435 81. Gordon, K. B., Papp, K. A., Hamilton, T. K., Walicke, P. A., Dummer,W., Li, N., Bresnahan, B. W., and Menter, A. (2003) Efalizumab for patients with moderate to severe plaque psoriasis: A randomized controlled trial. The Journal of the American Medical Association 290, 3073-3080 82. Leonardi, C. L. (2004) Efalizumab in the treatment of psoriasis. Dermatologic Therapy 17, 393-400 83. Strober, B. E. (2005) The treatment of psoriasis with etanercept. Seminars in Cutaneous Medicine and Surgery 24, 28-36 84. Gottlieb, A. B., Matheson, R. T., Lowe, N., Krueger, G. G., Kang, S., Goffe, B. S., Gaspari, A. A., Ling, M., Weinstein, G. D., Nayak, A., Gordon, K. B., and Zitnik, R. (2003) A randomized trial of etanercept as monotherapy for psoriasis. Archives Dermatology 139, 1627-1632 85. Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., and Gottlieb, A. B. (2003) Etanercept as monotherapy in patients with psoriasis. The New England Journal of Medicine 349, 2014-2022 86. Zeltser, R., Valle, L., Tanck, C., Holyst, M. M., Ritchlin, C., and Gaspari, A. A. (2001) Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: A recombinant tumor necrosis factor alpha receptor: Fc fusion protein. Archives Dermatology 137, 893-899 87. Smith, C. H., Jackson, K., Bashir, S. J., Perez, A., Chew, A. L., Powell, A. M., Wain, M., and Barker, J. N. (2006) Infliximab for severe, treatment-resistant psoriasis: A prospective, open-label study. The British Journal of Dermatology 155, 160-169 88. Reich, K., Nestle, F. O., Papp, K., Ortonne, J. P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., and Griffiths, C. E. (2005) Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial. The Lancet 366, 1367-1374 89. Gottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., and Menter, A. (2004b) Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology 51, 534-542 90. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Siegel, J. N.,Schwieterman, W. D., and Braun, M. M. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. The New England Journal of Medicine 345, 1098-1104 91. Pitarch, G., Sanchez-Carazo, J. L., Mahiques, L., Perez-Ferriols, M. A., and Fortea, J. M. (2007) Treatment of psoriasis with adalimumab. Clinical and Experimental Dermatology 32, 18-22 92. Gordon, K. B., Langley, R. G., Leonardi, C., Toth, D., Menter, M. A., Kang, S., Heffernan, M., Miller, B., Hamlin, R., Lim, L., Zhong, J., Hoffman, R., and Okun, M. M. (2006) Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study. Journal of the American Academy of Dermatology 55, 598-606 93. Papp, K. A. (2006) The long-term efficacy and safety of new biological therapies for psoriasis. Archives of Dermatological Research 298, 7-15 94. Naldi, L. (2004) Epidemiology of psoriasis. Current Drug Targets 3, 121-128 95. Palmblad, J., Hafstrom, I., and Ringertz, B. (1991) Antirheumatic effects of fasting. Rheumatic Diseases Clinics of North America 17, 351-362 96. Muller, H., de Toledo, F. W., and Resch, K. L. (2001) Fasting followed by vegetarian diet in patients with rheumatoid arthritis: A systematic review. Scandinavian Journal of Rheumatology 30, 1-10 97. Lithell, H., Bruce, A., Gustafsson, I. B., Hoglund, N. J., Karlstrom, B., Ljunghall, K., Sjolin, K., Venge, P., Werner, I., and Vessby, B. (1983) A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. Acta Dermato-Venereologica 63, 397-403 98. Kjeldsen-Kragh, J., Haugen, M., Borchgrevink, C. F., Laerum, E., Eek, M., Mowinkel, P., Hovi, K., and Forre, O. (1991) Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 338, 899-902 99. Grundy, S. M., Brewer, H. B., Jr., Cleeman, J. I., Smith, S. C., Jr., and Lenfant, C. (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438 100. Cohen, A. D., Gilutz, H., Henkin, Y., Zahger, D., Shapiro, J., Bonneh, D. Y., and Vardy, D. A. (2007) Psoriasis and the metabolic syndrome. Acta Dermato-Venereologica 87, 506-509 101. Ludwig, R. J., Herzog, C., Rostock, A., Ochsendorf, F. R., Zollner, T. M., Thaci, D., Kaufmann, R., Vogl, T. J., and Boehncke, W. H. (2007) Psoriasis: A possible risk factor for development of coronary artery calcification. The British Journal of Dermatology 156, 271-276 102. Kourosh, A. S., Miner, A., and Menter, A. (2008) Psoriasis as the marker of underlying systemic disease. Skin Therapy Letter 13, 1-5 103. Naldi, L., Chatenoud, L., Linder, D., Belloni Fortina, A., Peserico, A., Virgili, A. R., Bruni, P. L., Ingordo, V., Lo Scocco, G., Solaroli, C., Schena, D., Barba, A., Di Landro, A., Pezzarossa, E., Arcangeli, F., Gianni, C., Betti, R., Carli, P., Farris, A., Barabino, G. F., and La Vecchia, C. (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. The Journal of Investigative Dermatology 125, 61-67 104. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W., Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation 112, 1796-1808 105. Briganti, S., and Picardo, M. (2003) Antioxidant activity, lipid peroxidation and skin diseases. What's new. Journal of the European Academy of Dermatology and Venereology 17, 663-669 106. Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., Quintanilha, A., and Teixeira, F. (2001) Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clinica Chimica Acta; International Journal of Clinical Chemistry 303, 33-39 107. Brown, A. C., Hairfield, M., Richards, D. G., McMillin, D. L., Mein, E. A., and Nelson, C. D. (2004) Medical nutrition therapy as a potential complementary treatment for psoriasis--five case reports. Alternative Medicine Review 9, 297-307 108. Tanaka, S., Isoda, F., Ishihara, Y., Kimura, M., and Yamakawa, T. (2001) T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: Adequate weight reduction can be corrective. Clinical Endocrinology 54, 347-354 109. Rucevic, I., Perl, A., Barisic-Drusko, V., and Adam-Perl, M. (2003) The role of the low energy diet in psoriasis vulgaris treatment. Collegium Antropologicum 27 Suppl 1, 41-48 110. Hsieh, E. A., Chai, C. M., de Lumen, B. O., Neese, R. A., and Hellerstein, M. K. (2004) Dynamics of keratinocytes in vivo using HO labeling: A sensitive marker of epidermal proliferation state. The Journal of Investigative Dermatology 123, 530-536 111. Sterry, W., Strober, B. E., and Menter, A. (2007) Obesity in psoriasis: The metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. The British Journal of Dermatology 157, 649-655 112. Collin, P., and Reunala, T. (2003) Recognition and management of the cutaneous manifestations of celiac disease: A guide for dermatologists. American Journal of Clinical Dermatology 4, 13-20 113. McGough, N., and Cummings, J. H. (2005) Coeliac disease: A diverse clinical syndrome caused by intolerance of wheat, barley and rye. The Proceedings of the Nutrition Society 64, 434-450 114. Hischenhuber, C., Crevel, R., Jarry, B., Maki, M., Moneret-Vautrin, D. A., Romano, A., Troncone, R., and Ward, R. (2006) Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Alimentary Pharmacology &Therapeutics 23, 559-575 115. Rodrigo, L. (2006) Celiac disease. World Journal of Gastroenterology 12, 6585-6593 116. Leffler, D., Saha, S., and Farrell, R. J. (2003) Celiac disease. The American Journal of Managed Care 9, 825-831 117. Duggan, J. M. (2004) Coeliac disease: The great imitator. The Medical Journal of Australia 180, 524-526 118. Ojetti, V., Aguilar Sanchez, J., Guerriero, C., Fossati, B., Capizzi, R., De Simone, C., Migneco, A., Amerio, P., Gasbarrini, G., and Gasbarrini, A. (2003) High prevalence of celiac disease in psoriasis. The American Journal of Gastroenterology 98, 2574-2575 119. Woo, W. K., McMillan, S. A., Watson, R. G., McCluggage, W. G., Sloan, J. M., and McMillan, J. C. (2004) Coeliac disease-associated antibodies correlate with psoriasis activity. The British Journal of Dermatology 151, 891-894 120. Abenavoli, L., Proietti, I., Leggio, L., Ferrulli, A., Vonghia, L., Capizzi, R., Rotoli, M., Amerio, P. L., Gasbarrini, G., and Addolorato, G. (2006) Cutaneous manifestations in celiac disease. World Journal of Gastroenterol 12, 843-852 121. Abenavoli, L., Leggio, L., Gasbarrini, G., and Addolorato, G. (2007) Celiac disease and skin: Psoriasis association. World Journal of Gastroenterol 13, 2138-2139 122. Cardinali, C., Degl'innocenti, D., Caproni, M., and Fabbri, P. (2002) Is the search for serum antibodies to gliadin, endomysium and tissue transglutaminase meaningful in psoriatic patients? Relationship between the pathogenesis of psoriasis and coeliac disease. The British Journal of Dermatology 147, 187-188 123. Humbert, P., Bidet, A., Treffel, P., Drobacheff, C., and Agache, P. (1991) Intestinal permeability in patients with psoriasis. Journal of Dermatological Science 2, 324-326 124. Montalto, M., Cuoco, L., Ricci, R., Maggiano, N., Vecchio, F. M., and Gasbarrini, G. (2002) Immunohistochemical analysis of ZO-1 in the duodenal mucosa of patients with untreated and treated celiac disease. Digestion 65, 227-233 125. Mailliard, R. B., Egawa, S., Cai, Q., Kalinska, A., Bykovskaya, S. N., Lotze, M. T., Kapsenberg, M. L., Storkus, W. J., and Kalinski, P. (2002) Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: Helper role of CD8+ T cells in the development of T helper type 1 responses. The Journal of Experimental Medicine 195, 473-483 126. Molberg, O., McAdam, S. N., Korner, R., Quarsten, H., Kristiansen, C., Madsen, L., Fugger, L., Scott, H., Noren, O., Roepstorff, P., Lundin, K. E., Sjostrom, H., and Sollid, L. M. (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine 4, 713-717 127. Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Auricchio, S., Picard, J., Osman, M., Quaratino, S., and Londei, M. (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362, 30-37 128. Cellier, C., Flobert, C., Cormier, C., Roux, C., and Schmitz, J. (2000) Severe osteopenia in symptom-free adults with a childhood diagnosis of coeliac disease. Lancet 355, 80686 129. Hein, G., Abendroth, K., Muller, A., and Wessel, G. (1991) Studies on psoriatic osteopathy. Clinical Rheumatology 10, 13-17 130. Holick, M. F. (2003) Vitamin D: A millenium perspective. Journal of Cellular Biochemistry 88, 296-307 131. Kalayciyan, A., and Kotogyan, A. (2006) Psoriasis, enteropathy and antigliadin antibodies. The British Journal of Dermatology 154, 778-779
132. Chalmers, R. J., and Kirby, B. (2000) Gluten and psoriasis. The British Journal of Dermatology 142, 5-7 133. Damasiewicz-Bodzek, A., and Wielkoszy?ski, T. (2008) Serologic markers of celiac disease in psoriatic patients doi:10.1111/j.1468-3083.2008.02713.x. 134. Michaelsson, G., Gerden, B., Hagforsen, E., Nilsson, B., Pihl-Lundin, I., Kraaz, W., Hjelmquist, G., and Loof, L. (2000) Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. The British Journal of Dermatology 142, 44-51 135. Addolorato, G., Parente, A., de Lorenzi, G., D'Angelo Di Paola, M. E., Abenavoli, L., Leggio, L., Capristo, E., De Simone, C., Rotoli, M., Rapaccini, G. L., and Gasbarrini, G. (2003) Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature. Digestion 68, 9-12 136. Michaelsson, G., Ahs, S., Hammarstrom, I., Lundin, I. P., and Hagforsen, E. (2003) Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis. Acta Dermato-Venereologica 83, 425-429 137. Rapini, R. P. (2005) Practical Dermatopathology. Elsevier Mosby, Philadelphia, U.S.A. 373-375 138. Lopez, F., Belloc, F., Lacombe, F., Dumain, P., Reiffers, J., Bernard, P., and Boisseau, M. R. (1994) The labelling of proliferating cells by Ki67 and MIB-1 antibodies depends on the binding of a nuclear protein to the DNA. Experimental Cell Research 210, 145-153 139. Sblattero, D., Berti, I., Trevisiol, C., Marzari, R., Tommasini, A., Bradbury, A., Fasano, A., Ventura, A., and Not, T. (2000) Human recombinant tissue transglutaminase ELISA: An innovative diagnostic assay for celiac disease. The American Journal of Gastroenterology 95, 1253-1257 140. Lewis, N. R., and Scott, B. B. (2006) Systematic review: The use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Alimentary Pharmacology and Therapeutics 24, 47-54 141. Shaikh, S. R., and Edidin, M. (2006) Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. The American Journal of Clinical Nutrition 84, 1277-1289 142. Wathes, D. C., Abayasekara, D. R., and Aitken, R. J. (2007) Polyunsaturated fatty acids in male and female reproduction. Biology of Reproduction 77, 190-201 143. Mayer, K., Schaefer, M. B., and Seeger, W. (2006) Fish oil in the critically ill: From experimental to clinical data. Current Opinion in Clinical Nutrition and Metabolic Care 9, 140-148 144. Calder, P. C., and Grimble, R. F. (2002) Polyunsaturated fatty acids, inflammation and immunity. European Journal of Clinical Nutrition 56 Suppl 3, S14-19 145. Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W., Cannon, J. G., Rogers, T. S., Klempner, M. S., and Weber, P. C. (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. The New England Journal of Medicine 320, 265-271 146. Gibney, M. J., and Hunter, B. (1993) The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. European Journal of Clinical Nutrition 47, 255-259 147. Giardina, E., Sinibaldi, C., and Novelli, G. (2004) The psoriasis genetics as a model of complex disease. Current Drug Targets 3, 129-136 148. Simopoulos, A. P. (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition 21, 495-505 149. Lerman, R. H. (2006) Essential fatty acids. Alternative Therapies in Health and Medicine 12, 20-29 150. Mrowietz, U., Elder, J. T., and Barker, J. (2006) The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Archives of Dermatological Research 298, 309-319 151. Dunstan, J. A., and Prescott, S. L. (2005) Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Current Opinion in Allergy and Clinical Immunology 5, 215-221 152. Ruxton, C. H., Reed, S. C., Simpson, M. J., and Millington, K. J. (2004) The health benefits of omega-3 polyunsaturated fatty acids: A review of the evidence. Journal of Human Nutrition and Dietetics 17, 449-459 153. Sijben, J. W., and Calder, P. C. (2007) Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. The Proceedings of the Nutrition Society 66, 237-259 154. Boelsma, E., Hendriks, H. F., and Roza, L. (2001) Nutritional skin care: Health effects of micronutrients and fatty acids. The American Journal of Clinical Nutrition 73, 853-864 155. Simopoulos, A. P. (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition 21, 495-505 156. Sperling, R. I., Benincaso, A. I., Knoell, C. T., Larkin, J. K., Austen, K. F., and Robinson, D. R. (1993) Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. The Journal of Clinical Investigation 91, 651-660 157. Oh, R. (2005) Practical applications of fish oil (Omega-3 fatty acids) in primary care. The Journal of the American Board of Family Practice 18, 28-36 158. Mayser, P., Mayer, K., Mahloudjian, M., Benzing, S., Kramer, H. J., Schill, W. B., Seeger, W., and Grimminger, F. (2002) A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. Journal of Parenteral and Enteral Nutrition 26, 151-158 159. Ferrucci, L., Cherubini, A., Bandinelli, S., Bartali, B., Corsi, A., Lauretani, F., Martin, A., Andres-Lacueva, C., Senin, U., and Guralnik, J. M. (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. The Journal of Clinical Endocrinology and Metabolism 91, 439-446 160. Hughes, D. A., and Pinder, A. C. (1997) N-3 polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes and inhibit antigen-presentation in vitro. Clinical and Experimental Immunology 110, 516-523 161. Hughes, D. A., and Pinder, A. C. (2000) n-3 polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes. The American Journal of Clinical Nutrition 71, 357S-360S 162. Surette, M. E., Koumenis, I. L., Edens, M. B., Tramposch, K. M., Clayton, B., Bowton, D., and Chilton, F. H. (2003) Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: a randomized, placebo-controlled, parallel-group, prospective trial. Clinical Therapeutics 25, 972-979 163. Trebble, T. M., Wootton, S. A., Miles, E. A., Mullee, M., Arden, N. K., Ballinger, A. B., Stroud, M. A., Burdge, G. C., and Calder, P. C. (2003) Prostaglandin E2 production and T cell function after fish-oil supplementation: Response to antioxidant cosupplementation. The American Journal of Clinical Nutrition 78, 376-382 164. Devereux, G., and Seaton, A. (2005) Diet as a risk factor for atopy and asthma. The Journal of Allergy and Clinical Immunology 115, 1109-1117 165. Obata, T., Nagakura, T., Masaki, T., Maekawa, K., and Yamashita, K. (1999) Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clinical and Experimental Allergy 29, 1129-1135 166. Ziboh, V. A., Cohen, K. A., Ellis, C. N., Miller, C., Hamilton, T. A., Kragballe, K., Hydrick, C. R., and Voorhees, J. J. (1986) Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects. Archives of Dermatology 122, 1277-1282 167. Maurice, P. D., Allen, B. R., Barkley, A., and Stammers, J. (1987) Effects of dietary supplementation with eicosapentaenoic acid in patients with psoriasis. The British Journal of Dermatology 17B, 647-650 168. Bjorneboe, A., Smith, A. K., Bjorneboe, G. E., Thune, P. O., and Drevon, C. A. (1988) Effect of dietary supplementation with n-3 fatty acids on clinical manifestations of psoriasis. The British Journal of Dermatology 118, 77-83 169. Bittiner, S. B., Tucker, W. F., Cartwright, I., and Bleehen, S. S. (1988) A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet 1, 378-380 170. Lassus, A., Dahlgren, A. L., Halpern, M. J., Santalahti, J., and Happonen, H. P. (1990) Effects of dietary supplementation with polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis. The Journal of International Medical Research 18, 68-73 171. Soyland, E., Funk, J., Rajka, G., Sandberg, M., Thune, P., Rustad, L., Helland, S., Middelfart, K., Odu, S., and Falk, E. S. (1993) Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. The New England Journal of Medicine 328, 1812-1816 172. Grimminger, F., Mayser, P., Papavassilis, C., Thomas, M., Schlotzer, E., Heuer, K. U., Fuhrer, D., Hinsch, K. D., Walmrath, D., and Schill, W. B. (1993) A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. The Clinical Investigator 71, 634-643 173. Mayser, P., Mrowietz, U., Arenberger, P., Bartak, P., Buchvald, J., Christophers, E., Jablonska, S., Salmhofer, W., Schill, W. B., Kramer, H. J., Schlotzer, E., Mayer, K., Seeger, W., and Grimminger, F. (1998) Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial. Journal of the American Academy of Dermatology 38, 539-547 174. Rackal, J., and Barankin, B. (2004) The role of fish oils in psoriasis. Skinmed 3, 290-291 175. Dahan, A., and Altman, H. (2004) Food-drug interaction: Grapefruit juice augments drug bioavailability--mechanism, extent and relevance. European Journal of Clinical Nutrition 58, 1-9 176. Salim, A., Tan, E., Ilchyshyn, A., and Berth-Jones, J. (2006) Folic acid supplementation during treatment of psoriasis with methotrexate: A randomized, double-blind, placebo-controlled trial. The British Journal of Dermatology 154, 1169-1174
177. Zeiger, R. S., and Heller, S. (1995) The development and prediction of atopy in high-risk children: Follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. The Journal of Allergy and Clinical Immunology 95, 1179-1190 178. Arruda, L. K., Sole, D., Baena-Cagnani, C. E., and Naspitz, C. K. (2005) Risk factors for asthma and atopy. Current Opinion in Allergy and Clinical Immunology 5, 153-159 179. Novak, N., Bieber, T., and Leung, D. Y. (2003) Immune mechanisms leading to atopic dermatitis. The Journal of Allergy and Clinical Immunology 112, S128-139 180. Kerschenlohr, K., Decard, S., Przybilla, B., and Wollenberg, A. (2003) Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. The Journal of Allergy and Clinical Immunology 111, 869-874 181. O'Connell, E. J. (2003) Pediatric allergy: a brief review of risk factors associated with developing allergic disease in childhood. Annals of Allergy, Asthma & Immunology 90, 53-58 182. Eichenfield, L. F., Hanifin, J. M., Beck, L. A., Lemanske, R. F., Jr., Sampson, H. A., Weiss, S. T., and Leung, D. Y. (2003) Atopic dermatitis and asthma: Parallels in the evolution of treatment. Pediatrics 111, 608-616
183. Wuthrich, B., Cozzio, A., Roll, A., Senti, G., Kundig, T., and Schmid-Grendelmeier, P. (2007) Atopic eczema: Genetics or environment? Annals of Agricultural and Environmental Medicine 14, 195-201 184. Tricon, S., Willers, S., Smit, H. A., Burney, P. G., Devereux, G., Frew, A. J., Halken, S., Host, A., Nelson, M., Shaheen, S., Warner, J. O., and Calder, P. C. (2006) Nutrition and allergic disease. Clinical and Experimental Allergy Reviews 6, 117-188 185. Allam, J. P., and Novak, N. (2006) The pathophysiology of atopic eczema. Clinical and Experimental Dermatology 31, 89-93 186. Eichenfield, L. F., Hanifin, J. M., Luger, T. A., Stevens, S. R., and Pride, H. B. (2003) Consensus conference on pediatric atopic dermatitis. Journal of the American Academy of Dermatology 49, 1088-1095 187. Callard, R. E., and Harper, J. I. (2007) The skin barrier, atopic dermatitis and allergy: A role for Langerhans cells? Trends in Immunology 28, 294-298 188. Jensen, J. M., Folster-Holst, R., Baranowsky, A., Schunck, M., Winoto-Morbach, S., Neumann, C., Schutze, S., and Proksch, E. (2004) Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. The Journal of Investigative Dermatology 122, 1423-1431 189. Sator, P. G., Schmidt, J. B., and Honigsmann, H. (2003) Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. Journal of the American Academy of Dermatology 48, 352-358 190. Rippke, F., Schreiner, V., Doering, T., and Maibach, H. I. (2004) Stratum corneum pH in atopic dermatitis: Impact on skin barrier function and colonization with Staphylococcus Aureus. American Journal of Clinical Dermatology 5, 217-223 191. Vasilopoulos, Y., Cork, M. J., Murphy, R., Williams, H. C., Robinson, D. A., Duff, G. W., Ward, S. J., and Tazi-Ahnini, R. (2004) Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. The Journal of Investigative Dermatology 123, 62-66 192. Akdis, C. A., Akdis, M., Bieber, T., Bindslev-Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y., Lipozencic, J., Luger, T. A., Muraro, A., Novak, N., Platts-Mills, T. A., Rosenwasser, L., Scheynius, A., Simons, F. E., Spergel, J., Turjanmaa, K., Wahn, U., Weidinger, S., Werfel, T., and Zuberbier, T. (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. The Journal of Allergy and Clinical Immunology 118, 152-169 193. Langan, S. M., and Williams, H. C. (2006) What causes worsening of eczema? A systematic review. The British Journal of Dermatology 155, 504-514
194. Sidenius, K. E., Hallas, T. E., Brygge, T., Poulsen, L. K., and Mosbech, H. (2002) House dust mites and their allergens at selected locations in the homes of house dust mite-allergic patients. Clinical and Experimental Allergy 32, 1299-1304 195. Leung, D. Y. (2003) Infection in atopic dermatitis. Current Opinion in Pediatrics 15, 399-404 196. Ou, L. S., Goleva, E., Hall, C., and Leung, D. Y. (2004) T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. The Journal of Allergy and Clinical Immunology 113, 756-763 197. Laouini, D., Kawamoto, S., Yalcindag, A., Bryce, P., Mizoguchi, E., Oettgen, H., and Geha, R. S. (2003) Epicutaneous sensitization with superantigen induces allergic skin inflammation. The Journal of Allergy and Clinical Immunology 112, 981-987 198. Sampson, H. A. (2004) Update on food allergy. The Journal of Allergy and Clinical Immunology 113, 805-819 199. Werfel, T., and Breuer, K. (2004) Role of food allergy in atopic dermatitis. Current Opinion in Allergy and Clinical Immunology 4, 379-385 200. Pallanti, S., Lotti, T., and Urpe, M. (2005) Psychoneuroimmunodermatology of atopic dermatitis: from empiric data to the evolutionary hypothesis. Dermatologic Clinics 23, 695-701 201. Naldi, L., Chatenoud, L., Linder, D., Belloni Fortina, A., Peserico, A., Virgili, A. R., Bruni, P. L., Ingordo, V., Lo Scocco, G., Solaroli, C., Schena, D., Barba, A., Di Landro, A., Pezzarossa, E., Arcangeli, F., Gianni, C., Betti, R., Carli, P., Farris, A., Barabino, G. F., and La Vecchia, C. (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. The Journal of InvestigativeDermatology 125, 61-67 202. Schmitt, J., Langan, S., and Williams, H. C. (2007) What are the best outcome measurements for atopic eczema? A systematic review. The Journal of Allergy and Clinical Immunology 120, 1389-1398 203. European Task Force on Atopic Dermatitis. (1993)Severity scoring of atopic dermatitis: The SCORAD index. Dermatology 186, 23-31 204. Oranje, A. P., Glazenburg, E. J., Wolkerstorfer, A., and de Waard-van der Spek, F. B. (2007) Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. The British Journal of Dermatology 157, 645-648 205. Hanifin J.M., Rajka G. (1983) Diagnostic features of atopic dermatitis. Acta Dermato Venereologica 92. (suppl): 44-47 206. Freedberg, I. M., Eisen, A. Z., Wolff, K., Austen, K. F., Goldsmith, L. A., Katz, S. (2003) Atopic Dermatitis Fitzpatrick's Dermatology In General Medicine. McGraw Hill, New York.1, 146-158 207. Buys, L. M. (2007) Treatment options for atopic dermatitis. American Family Physician 75, 523-528 208. Hanifin, J. M., Cooper, K. D., Ho, V. C., Kang, S., Krafchik, B. R., Margolis, D. J., Schachner, L. A., Sidbury, R., Whitmore, S. E., Sieck, C. K., and Van Voorhees, A. S. (2004) Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". Journal of the American Academy of Dermatology 50, 391-404 209. Niemeier, V., Kupfer, J., Schill, W. B., and Gieler, U. (2005) Atopic dermatitis -- topical therapy: Do patients apply much too little? The Journal of Dermatological Treatment 16, 95-101 210. Klein, P. A., and Clark, R. A. (1999) An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Archives of Dermatology 135, 1522-1525 211. Herman, S. M., and Vender, R. B. (2003) Antihistamines in the treatment of dermatitis. Journal of Cutaneous Medicine and Surgery 7, 467-473 212. Schwarz, T. (2005b) Ultraviolet radiation--immune response. Journal der Deutschen Dermatologischen Gesellschaft 3 Suppl 2, S11-18 213. Buggiani, G., Ricceri, F., and Lotti, T. (2008) Atopic dermatitis. Dermatologic Therapy 21, 96-100 214. Isolauri, E. (2004) Dietary modification of atopic disease: Use of probiotics in the prevention of atopic dermatitis. Current Allergy and Asthma Reports 4, 270-275 215. Callen, J., Chamlin, S., Eichenfield, L. F., Ellis, C., Girardi, M., Goldfarb, M., Hanifin, J., Lee, P., Margolis, D., Paller, A. S., Piacquadio, D., Peterson, W., Kaulback, K., Fennerty, M., and Wintroub, B. U. (2007) A systematic review of the safety of topical therapies for atopic dermatitis. The British Journal of Dermatology 156, 203-221
216. Charman, C. R., Morris, A. D., and Williams, H. C. (2000) Topical corticosteroid phobia in patients with atopic eczema. The British Journal of Dermatology 142, 931-936 217. Curran, M. P., Scott, L. J., and Perry, C. M. (2004) Cetirizine: A review of its use in allergic disorders. Drugs 64, 523-561 218. Golightly, L. K., and Greos, L. S. (2005) Second-generation antihistamines: Actions and efficacy in the management of allergic disorders. Drugs 65, 341-384 219. Furrie, E. (2005) Probiotics and allergy. The Proceedings of the Nutrition Society 64, 465-469 220. Strachan, D. P. (1989) Hay fever, hygiene, and household size. British Medical Journal (Clinical Research ed) 299, 1259-1260 221. Lee, J., Seto, D., and Bielory, L. (2008) Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. The Journal of Allergy and Clinical Immunology 121, 116-121 222. Lilly, D. M., and Stillwell, R. H. (1965) Probiotics: Growth-promoting factors produced by microorganisms. Science 147, 747-748 223. Kullen, M. J., and Bettler, J. (2005) The delivery of probiotics and prebiotics to infants. Current Pharmaceutical Design 11, 55-74 224. Morais, M. B., and Jacob, C. M. (2006) The role of probiotics and prebiotics in pediatric practice. Jornal de Pediatria 82, S189-197 225. Macfarlane, G. T., and Cummings, J. H. (2002) Probiotics, infection and immunity. Current Opinion in Infectious Diseases 15, 501-506 226. Montalto, M., Arancio, F., Izzi, D., Cuoco, L., Curigliano, V., Manna, R., and Gasbarrini, G. (2002) Probiotics: History, definition, requirements and possible therapeutic applications. Annali Italiani di Medicina Interna 17, 157-165 227. Prescott, S. L., and Bjorksten, B. (2007) Probiotics for the prevention or treatment of allergic diseases. The Journal of Allergy and Clinical Immunology 120, 255-262 228. Zollner, T. M., Wichelhaus, T. A., Hartung, A., Von Mallinckrodt, C., Wagner, T. O., Brade, V., and Kaufmann, R. (2000) Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clinical and Experimental Allergy 30, 994-1000 229. Heller, F., and Duchmann, R. (2003) Intestinal flora and mucosal immune responses. International Journal of Medical Microbiology 293, 77-86 230. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H., and Salminen, S. (2001) Probiotics: Effects on immunity. The American Journal of Clinical Nutrition 73, 444S-450S 231. Sanfilippo, L., Li, C. K., Seth, R., Balwin, T. J., Menozzi, M. G., and Mahida, Y. R. (2000) Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-beta) by human colonic epithelial cells. Clinical and Experimental Immunology 119, 456-463 232. Hansen, G., McIntire, J. J., Yeung, V. P., Berry, G., Thorbecke, G. J., Chen, L., DeKruyff, R. H., and Umetsu, D. T. (2000) CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. The Journal of Clinical Investigation 105, 61-70 233. Gaskins, H. R. (1997) Immunological aspects of host/microbiota interactions at the intestinal epithelium. In: Mackie, R. I., White, B. A. and Isaacson, R. E. Editors, Gastrointestinal Microbiology, International Thomson Publishing, New York 537–587 234. Murch, S. H. (2005) Probiotics as mainstream allergy therapy? Archives of Disease in Childhood 90, 881-882 235. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., and Isolauri, E. (2001) Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 357, 1076-1079 236. Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H., and Isolauri, E. (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869-1871 237. Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., and Kuitunen, M. (2007) Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. The Journal of Allergy and Clinical Immunology 119, 192-198 238. Isolauri, E., Arvola, T., Sutas, Y., Moilanen, E., and Salminen, S. (2000) Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 30, 1604-1610 239. Majamaa, H., and Isolauri, E. (1997) Probiotics: A novel approach in the management of food allergy. The Journal of Allergy and Clinical Immunology 99, 179-185
240. Kirjavainen, P. V., Salminen, S. J., and Isolauri, E. (2003) Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability. Journal of Pediatric Gastroenterology and Nutrition 36, 223-227 241. Abrahamsson, T. R., Jakobsson, T., Bottcher, M. F., Fredrikson, M., Jenmalm, M. C., Bjorksten, B., and Oldaeus, G. (2007) Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. The Journal of Allergy and Clinical Immunology 119, 1174-1180 242. Weston, S., Halbert, A., Richmond, P., and Prescott, S. L. (2005) Effects of probiotics on atopic dermatitis: A randomised controlled trial. Archives of Disease in Childhood 90, 892-897 243. Viljanen, M., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., and Kuitunen, M. (2005) Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy 60, 494-500 244. Rosenfeldt, V., Benfeldt, E., Nielsen, S. D., Michaelsen, K. F., Jeppesen, D. L., Valerius, N. H., and Paerregaard, A. (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. The Journal of Allergy and Clinical Immunology 111, 389-395 245. Cross, M. L., Stevenson, L. M., and Gill, H. S. (2001) Anti-allergy properties of fermented foods: An important immunoregulatory mechanism of lactic acid bacteria? International Immunopharmacology 1, 891-901 246. Macfarlane, G. T., and Cummings, J. H. (2002) Probiotics, infection and immunity. Current Opinion in Infectious Diseases 15, 501-506 247. Erickson, K. L., and Hubbard, N. E. (2000) Probiotic immunomodulation in health and disease. The Journal of Nutrition 130, 403S-409S 248. Galdeano, C. M., de Moreno de LeBlanc, A., Vinderola, G., Bonet, M. E., and Perdigon, G. (2007) Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria. Clinical and Vaccine Immunology 14, 485-492 249. Yan, F., and Polk, D. B. (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. The Journal of Biological Chemistry 277, 50959-50965 250. Boyle, R. J., and Tang, M. L. (2006) The role of probiotics in the management of allergic disease. Clinical and Experimental Allergy 36, 568-576 251. Niers, L. E., Timmerman, H. M., Rijkers, G. T., van Bleek, G. M., van Uden, N. O., Knol, E. F., Kapsenberg, M. L., Kimpen, J. L., and Hoekstra, M. O. (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clinical and Experimental Allergy 35, 1481-148 252. Veckman, V., Miettinen, M., Matikainen, S., Lande, R., Giacomini, E., Coccia, E. M., and Julkunen, I. (2003) Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. Journal of Leukocyte Biology 74, 395-402
253. Braat, H., de Jong, E. C., van den Brande, J. M., Kapsenberg, M. L., Peppelenbosch, M. P., van Tol, E. A., and van Deventer, S. J. (2004) Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. Journal of Molecular Medicine 82, 197-205 254. Matsuguchi, T., Takagi, A., Matsuzaki, T., Nagaoka, M., Ishikawa, K., Yokokura, T., and Yoshikai, Y. (2003) Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clinical and Diagnostic Laboratory Immunology 10, 259-266 255. Pessi, T., Sutas, Y., Hurme, M., and Isolauri, E. (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clinical and Experimental Allergy 30, 1804-1808 256. Pohjavuori, E., Viljanen, M., Korpela, R., Kuitunen, M., Tiittanen, M., Vaarala, O., and Savilahti, E. (2004) Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. The Journal of Allergy and Clinical Immunology 114, 131-136 257. Prescott, S. L., Dunstan, J. A., Hale, J., Breckler, L., Lehmann, H., Weston, S., and Richmond, P. (2005) Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clinical and Experimental Allergy 35, 1557-1564 258. Viljanen, M., Pohjavuori, E., Haahtela, T., Korpela, R., Kuitunen, M., Sarnesto, A., Vaarala, O., and Savilahti, E. (2005) Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. The Journal of Allergy and Clinical Immunology 115, 1254-1259 259. Muraro, A., Dreborg, S., Halken, S., Host, A., Niggemann, B., Aalberse, R., Arshad, S. H., von Berg, A., Carlsen, K. H., Duschen, K., Eigenmann, P., Hill, D., Jones, C., Mellon, M., Oldeus, G., Oranje, A., Pascual, C., Prescott, S., Sampson, H., Svartengren, M., Vandenplas, Y., Wahn, U., Warner, J. A., Warner, J. O., Wickman, M., and Zeiger, R. S. (2004a) Dietary prevention of allergic diseases in infants and small children. Part II. Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases. Pediatric Allergy and Immunology 15, 196-205 260. Muraro, A., Dreborg, S., Halken, S., Host, A., Niggemann, B., Aalberse, R., Arshad, S. H., Berg Av, A., Carlsen, K. H., Duschen, K., Eigenmann, P., Hill, D., Jones, C., Mellon, M., Oldeus, G., Oranje, A., Pascual, C., Prescott, S., Sampson, H., Svartengren, M., Vandenplas, Y., Wahn, U., Warner, J. A., Warner, J. O., Wickman, M., and Zeiger, R. S. (2004b) Dietary prevention of allergic diseases in infants and small children. Part III: Critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatric Allergy and Immunology 15, 291-307 261. von Berg, A., Koletzko, S., Grubl, A., Filipiak-Pittroff, B., Wichmann, H. E., Bauer, C. P., Reinhardt, D., and Berdel, D. (2003) The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: The German Infant Nutritional Intervention Study, a randomized double-blind trial. The Journal of Allergy and Clinical Immunology 111, 533-540 262. Osborn, D. A., and Sinn, J. (2006) Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database of Systematic Reviews (Online), CD003664 263. Allen, K. J., Hill, D. J., and Heine, R. G. (2006) 4. Food allergy in childhood. The Medical Journal of Australia 185, 394-400 264. Host, A., Halken, S., Jacobsen, H. P., Christensen, A. E., Herskind, A. M., and Plesner, K. (2002) Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood. Pediatric Allergy and Immunology 13 Suppl 15, 23-28 265. Kitz, R., Rose, M. A., Schonborn, H., Zielen, S., and Bohles, H. J. (2006) Impact of early dietary gamma-linolenic acid supplementation on atopic eczema in infancy. Pediatr Allergy Immunology 17, 112-117 266. Friedman, N. J., and Zeiger, R. S. (2005) The role of breast-feeding in the development of allergies and asthma. The Journal of Allergy and Clinical Immunology 115, 1238-1248 267. Sears, M. R., Greene, J. M., Willan, A. R., Taylor, D. R., Flannery, E. M., Cowan, J. O., Herbison, G. P., and Poulton, R. (2002) Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: A longitudinal study. Lancet 360, 901-907 268. (2000) American Academy of Pediatrics. Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 106, 346-349 269. Host, A. (1994) Cow's milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects. Pediatric Allergy and Immunology 5, 1-36 270. Hamelmann, E., Beyer, K., Gruber, C., Lau, S., Matricardi, P. M., Nickel, R., Niggemann, B., and Wahn, U. (2008) Primary prevention of allergy: Avoiding risk or providing protection? Clinical and Experimental Allergy 38, 233-245 271. Beyer, K. (2007) Hypoallergenicity: a principle for the treatment of food allergy. Nestle Nutrition Workshop Series 59, 37-43; discussion 43-37 272. Estrada-Reyes, E., Garcia-Hernandez, G., Martinez-Gimeno, A., and Nava-Ocampo, A. A. (2006) Effect of extensively hydrolyzed milk formula on growth and resistance to bronchitis and atopic dermatitis in infants and toddlers. Journal of Investigational Allergology & Clinical Immunology 16, 183-187 273. Caffarelli, C., Plebani, A., Poiesi, C., Petroccione, T., Spattini, A., and Cavagni, G. (2002) Determination of allergenicity to three cow's milk hydrolysates and an amino acid-derived formula in children with cow's milk allergy. Clinical and Experimental Allergy 32, 74-79 274. Niggemann, B., Binder, C., Dupont, C., Hadji, S., Arvola, T., and Isolauri, E. (2001) Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatric Allergy and Immunology 12, 78-82 275. Seppo, L., Korpela, R., Lonnerdal, B., Metsaniitty, L., Juntunen-Backman, K., Klemola, T., Paganus, A., and Vanto, T. (2005) A follow-up study of nutrient intake, nutritional status, and growth in infants with cow milk allergy fed either a soy formula or an extensively hydrolyzed whey formula. The American Journal of Clinical Nutrition 82, 140-145 276. von Berg, A., Koletzko, S., Filipiak-Pittroff, B., Laubereau, B., Grubl, A., Wichmann, H. E., Bauer, C. P., Reinhardt, D., and Berdel, D. (2007) Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: Three-year results of the German Infant Nutritional Intervention Study. The Journal of Allergy and Clinical Immunology 119, 718-725 277. Halken, S., Hansen, K. S., Jacobsen, H. P., Estmann, A., Faelling, A. E., Hansen, L. G., Kier, S. R., Lassen, K., Lintrup, M., Mortensen, S., Ibsen, K. K., Osterballe, O., and Host, A. (2000) Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: A prospective, randomized study. Pediatric Allergy and Immunology 11, 149-161 278. Arvola, T., Moilanen, E., Vuento, R., and Isolauri, E. (2004) Weaning to hypoallergenic formula improves gut barrier function in breast-fed infants with atopic eczema. Journal of Pediatric Gastroenterology and Nutrition 38, 92-96 279. Oldaeus, G., Anjou, K., Bjorksten, B., Moran, J. R., and Kjellman, N. I. (1997) Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood 77, 4-10 280. Han, Y. S., Park, H. Y., Ahn, K. M., Lee, J. S., Choi, H. M., and Lee, S. I. (2003) Short-term effect of partially hydrolyzed formula on the prevention of development of atopic dermatitis in infants at high risk. Journal of Korean Medical Science 18, 547-551 281. Szajewska, H., Mrukowicz, J. Z., Stoinska, B., and Prochowska, A. (2004) Extensively and partially hydrolysed preterm formulas in the prevention of allergic diseases in preterm infants: a randomized, double-blind trial. Acta Paediatrica 93, 1159-1165 282. Nentwich, I., Michkova, E., Nevoral, J., Urbanek, R., and Szepfalusi, Z. (2001) Cow's milk-specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy 56, 1144-1156 283. Manku, M. S., Horrobin, D. F., Morse, N., Kyte, V., Jenkins, K., Wright, S., and Burton, J. L. (1982) Reduced levels of prostaglandin precursors in the blood of atopic patients: Defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins, Leukotrienes, and Medicine 9, 615-628 284. Melnik, B., and Plewig, G. (1992) Are disturbances of omega-6-fatty acid metabolism involved in the pathogenesis of atopic dermatitis? Acta Dermato-Venereologica. Supplementum (Stockh) 176, 77-85 285. Ziboh, V. A. (1994) Essential fatty acids/eicosanoid biosynthesis in the skin: biological significance. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 205, 1-11 286. Horrobin, D. F. (2000) Essential fatty acid metabolism and its modification in atopic eczema. The American Journal of Clinical Nutrition 71, 367S-372S 287. van Gool, C. J., Zeegers, M. P., and Thijs, C. (2004) Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebo-controlled trials. The British Journal of Dermatology 150, 728-740 288. Macheleidt, O., Kaiser, H. W., and Sandhoff, K. (2002) Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. The Journal of Investigative Dermatology 119, 166-173 289. Manku, M. S., Horrobin, D. F., Morse, N. L., Wright, S., and Burton, J. L. (1984) Essential fatty acids in the plasma phospholipids of patients with atopic eczema. The British Journal of Dermatology 110, 643-648 290. Proksch, E., Folster-Holst, R., and Jensen, J. M. (2006) Skin barrier function, epidermal proliferation and differentiation in eczema. Journal of Dermatological Science 43, 159-169 291. Simopoulos, A. P. (2002) The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine and Pharmacotherapy 56, 365-379 292. Siddiqui, R. A., Shaikh, S. R., Sech, L. A., Yount, H. R., Stillwell, W., and Zaloga, G. P. (2004) Omega 3-fatty acids: Health benefits and cellular mechanisms of action. Mini Reviews in Medicinal Chemistry 4, 859-871 293. Miles, E. A., and Calder, P. C. (1998) Modulation of immune function by dietary fatty acids. The Proceedings of the Nutrition Society 57, 277-292 294. Grimble, R. F. (1998) Dietary lipids and the inflammatory response. The Proceedings of the Nutrition Society 57, 535-542 295. Denys, A., Hichami, A., and Khan, N. A. (2005) n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. Journal of Lipid Research 46, 752-758 296. Calder, P. C., Yaqoob, P., Thies, F., Wallace, F. A., and Miles, E. A. (2002) Fatty acids and lymphocyte functions. The British Journal of Nutrition 87 Suppl 1, S31-48 297. Miles, E. A., Aston, L., and Calder, P. C. (2003) In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures. Clinical and Experimental Allergy 33, 624-632 298. Koch, C., Dolle, S., Metzger, M., Rasche, C., Jungclas, H., Ruhl, R., Renz, H., and Worm, M. (2008) Docosahexaenoic acid (DHA) supplementation in atopic eczema: A randomized, double-blind, controlled trial. British Journal of Dermatology 158, 786-792 299. Dunstan, J. A., Mori, T. A., Barden, A., Beilin, L. J., Taylor, A. L., Holt, P. G., and Prescott, S. L. (2003) Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial. The Journal of Allergy and Clinical Immunology 112, 1178-1184 300. Bjorneboe, A., Soyland, E., Bjorneboe, G. E., Rajka, G., and Drevon, C. A. (1987) Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. The British Journal of Dermatology 117, 463-469
301. Soyland, E., Funk, J., Rajka, G., Sandberg, M., Thune, P., Rustad, L., Helland, S., Middelfart, K., Odu, S., Falk, E. S., and et al. (1994) Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. The British Journal of Dermatology 130, 757-764 302. Mayser, P., Mayer, K., Mahloudjian, M., Benzing, S., Kramer, H. J., Schill, W. B., Seeger, W., and Grimminger, F. (2002) A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. Journal of Parenteral and Enteral Nutrition 26, 151-158 303. Kitz, R., Rose, M. A., Schonborn, H., Zielen, S., and Bohles, H. J. (2006) Impact of early dietary gamma-linolenic acid supplementation on atopic eczema in infancy. Pediatric Allergy and Immunology 17, 112-117 304. Berth-Jones, J., and Graham-Brown, R. A. (1993) Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 341, 1557-1560 305. Henz, B. M., Jablonska, S., van de Kerkhof, P. C., Stingl, G., Blaszczyk, M., Vandervalk, P. G., Veenhuizen, R., Muggli, R., and Raederstorff, D. (1999) Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. The British Journal of Dermatology 14
|